Successful Treatment with Imatinib Combined with Less Intensive Chemotherapy (Vincristine and Dexamethasone) as Induction Therapy in a Very Elderly Patient with Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia

[1] Dombret H(2002)Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 trial Blood. 100 2357-2366

[2] Gabert J(2003)Bone marrow transplant in Ph Bone Marrow Transplant. 31 623-632

[3] Boiron JM(2004) ALL patients Int J Hematol. 79 79-84

[4] Avivi I(2004)Twenty years’ experience in allo-geneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group Blood. 103 4396-4407

[5] Goldstone AH.(2004)Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate Blood. 104 3507-3512

[6] Iida H(2006)Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia J Clin Oncol. 24 460-466

[7] Sao H(2006)High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group Blood. 108 1469-1477

[8] Kitaori K(2006)Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph Leukemia 20 400-403

[9] Thomas DA(2004) ALL) Hematol J. 5 S112.-S112.

[10] Faderl S(undefined)High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia undefined undefined undefined-undefined

[1] Dombret H(2002)Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 trial Blood. 100 2357-2366

[2] Gabert J(2003)Bone marrow transplant in Ph Bone Marrow Transplant. 31 623-632

[3] Boiron JM(2004) ALL patients Int J Hematol. 79 79-84

[4] Avivi I(2004)Twenty years’ experience in allo-geneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group Blood. 103 4396-4407

[5] Goldstone AH.(2004)Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate Blood. 104 3507-3512

[6] Iida H(2006)Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia J Clin Oncol. 24 460-466

[7] Sao H(2006)High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group Blood. 108 1469-1477

[8] Kitaori K(2006)Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph Leukemia 20 400-403

[9] Thomas DA(2004) ALL) Hematol J. 5 S112.-S112.

[10] Faderl S(undefined)High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia undefined undefined undefined-undefined